Medelis is top oncology CRO — with a specialization in challenging oncology studies including cutting-edge immunotherapy trials. (Feel free to check out our webinar about the irRC in immunotherapy studies.)
Since we specialize in oncology, our entire team has deep oncology trial experience and expertise — from our world-class medical advisory board to our clinical team members and medical personnel. This critical first-hand experience in the complex issues often associated with oncology clinical trials means that highly experienced resources will be working on your study.
We’ll complete your study on time and on budget. Have the comfort of a highly-skilled, experienced and dedicated team by your side throughout your trial.
As a top oncology CRO, we’ve handled most targets within oncology. Our experience and our relationships enable us to enroll the patients you need to meet your timelines and get the data for your next clinical move.
If you’re tired of fighting through staff turnover or change orders with your big CRO, or if your study is missing timelines or over budget, or if you want the comfort of a dedicated expert oncology team, let’s talk.
With Medelis, you get:
Contact us to start a conversation about your program.
The content in this guide is designed for CMOs, VPs and Directors of Clinical Development, the clinical operations team and any others involved in designing and managing immuno-oncology studies.
A GUIDE FOR CHOOSING THE RIGHT IMMUNO-ONCOLOGY CRO
We’d enjoy hearing from you and can provide feedback about your study design, investigators, patient recruitment, timelines, budget and likely outcomes.